BioVie Inc. (BIVI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 9, 2022, covers the results of BioVie Inc.'s 2022 Annual Meeting of Stockholders. The company is a Nevada corporation with its principal executive offices in Carson City, NV, and its Class A Common Stock trades on the NASDAQ Stock Market under the symbol "BIVI".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results rather than financial performance.
Material Changes and Voting Results
The primary material event reported is the successful election of all eight director nominees and the ratification of the independent auditor. Voting results were as follows:
- Election of Directors: All nominees received significant majority support. For example, Sigmund Rogich received 23,923,084 votes "For" versus 41,542 "Withheld". Broker non-votes totaled 1,760,515 for each director proposal.
- Approval of Auditors: Stockholders approved the appointment of EisnerAmper LLP for the 2023 fiscal year with 25,617,605 votes "For", 94,990 "Against", and 12,546 "Abstain".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural outcomes of the annual meeting.
Key Facts for Investor Verification
- Verify the composition of the newly elected Board of Directors, which includes Terren S. Peizer, Cuong Do, Jim Lang, Michael Sherman, Richard J. Berman, Steve Gorlin, Robert Hariri, and Sigmund Rogich.
- Confirm the appointment of EisnerAmper LLP as the independent registered public accounting firm for the 2023 fiscal year.
- Note the significant number of broker non-votes (1,760,515) recorded for the director elections, indicating shares held by brokers that were not voted on these matters.